Clinical Trial: Stimulating Fat Tissue Storage with Niacin to Reduce Fat Accumulation in the Liver.

U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT06843148) titled 'Stimulating Fat Tissue Storage with Niacin to Reduce Fat Accumulation in the Liver.' on Feb. 12.

Brief Summary: Metabolic dysfunction-associated steatotic liver disease (MASLD) (aka non-alcoholic fatty liver disease), commonly occurring in individuals with obesity and type 2 diabetes can lead to liver inflammation/ fibrosis. MASLD results from fat being disproportionately deposited in the liver.

The goal of this mechanistic study is to investigate metabolic response in patients aged 50 to 80 years with non-alcoholic fatty liver disease, after niacin (vitamin B3) treatment.

The main questions it aims to answer are:

* Does Niacin l...